CCL2 and metabolic dysfunction-associated steatohepatitis: To correlate with MCP-1 activation in mutant BMDMs (Fig. 2G), we determined MCP-1 expression not only in the liver but also in subcutaneous fat in our mouse cohort, because inflammation in adipose tissues during NASH is shown to be mediated by MCP-1/CCR2 pathway (41).